The global assisted reproductive technology (ART) market was valued at USD 21.32 billion in 2018 and is projected to reach USD 45.06 billion by 2026, growing at a CAGR of 9.8% during the forecast period. In 2018, Europe led the global market with a share of 41.18%.
Assisted reproductive technologies, also known as assisted reproductive treatments, include various techniques used to address infertility. These treatments encompass a wide range of procedures tailored to the specific causes of infertility.
For More Information, Visit – https://www.fortunebusinessinsights.com/industry-reports/assisted-reproductive-technology-art-market-101811
In August 2018, GI Partners made a significant move by acquiring California Cryobank (CCB) and Cord Blood Registry (CBR) to strengthen its position in the stem cell storage and reproductive tissue services markets. This acquisition has enabled the company to expand its footprint in the ART (Assisted Reproductive Technology) industry, offering advanced solutions for fertility treatments, stem cell preservation, and reproductive health services globally. By integrating CCB and CBR's established expertise, GI Partners aims to meet the growing demand for innovative fertility and reproductive tissue services.